Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
21-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
advertisement
Classification List
1 General aspects
0
1.1
Epidemiology
8
1.2 Population genetics
0
1.3
Pathogenesis
1
1.4
Quality of life
13
1.5
Glaucomas as cause of blindness
4
1.6
Prevention and screening
9
2 Anatomical structures in glaucoma
0
2.1
Conjunctiva
10
2.2
Cornea
19
2.3
Sclera
7
2.4
Anterior chamber angle
7
2.5 Meshwork
0
2.5.1
Trabecular meshwork
15
2.5.2
Schlemms canal
5
2.5.3 Scleral outlet channels
0
2.6 Aqueous humor dynamics
0
2.6.1 Production
0
2.6.2 Outflow
0
2.6.2.1
Trabecular meshwork
6
2.6.2.2 Uveoscleral
0
2.6.3
Compostion
9
2.7 Episcleral veins and venous pressure
0
2.8
Iris
5
2.9
Ciliary body
2
2.10 Lens
0
2.11
Vitreous body
1
2.12
Choroid, peripapillary choroid, peripapillary atrophy
6
2.13
Retina and retinal nerve fibre layer
38
2.14
Optic disc
36
2.15
Optic nerve
4
2.16
Chiasma and retrochiasmal central nervous system
14
2.17
Stem cells
4
2.20 Other
0
3 Laboratory methods
0
3.1
Microscopy
2
3.2 Electron microscopy
0
3.3
Immunohistochemistry
1
3.4 Molecular genetics
0
3.4.1
Linkage studies
2
3.4.2
Gene studies
20
3.5
Molecular biology incl. SiRNA
20
3.6
Cellular biology
41
3.7
Biochemistry
20
3.8
Pharmacology
17
3.9
Pathophysiology
20
3.10
Immunobiology
9
3.11 Pharmacogenetics
0
3.12
Proteomics
7
3.13 In vivo imaging
0
3.13.1 Laser Scanning
0
3.13.1.1 Confocal Scanning Laser Ophthalmoscopy
0
3.13.1.2 Confocal Scanning Laser Polarimetry
0
3.13.2 Optical Coherence Tomography
0
3.13.2.1 Anterior Segment
0
3.13.2.2
Posterior Segment
1
3.13.3
RGC Imaging
1
3.13.4 Other
0
3.20 Other
0
4 Tissue culture of ocular cells
0
5 Experimental glaucoma; animal models
0
5.1
Rodent
33
5.2
Primates
3
5.3
Other
9
6 Clinical examination methods
0
6.1 Intraocular pressure measurement; factors affecting IOP
0
6.1.1
Devices, techniques
12
6.1.2
Fluctuation, circadian rhythms
6
6.1.3
Factors affecting IOP
16
6.2
Tonography, aqueous flow measurement (see also 2.6)
2
6.3 Biomicroscopy (slitlamp)
0
6.3.1 Anterior segment
0
6.3.2
Posterior segment
1
6.4
Gonioscopy
5
6.5 Ophthalmoscopy
0
6.6 Visual field examination and other visual function tests
0
6.6.1 Conventional manual
0
6.6.2
Automated
32
6.6.3
Special methods (e.g. color, contrast, SWAP etc.)
16
6.7
Electro-ophthalmodiagnosis
10
6.8 Photography
0
6.8.1 Anterior segment
0
6.8.2
Posterior segment
18
6.9 Computerized image analysis
0
6.9.1 Laser scanning
0
6.9.1.1
Confocal Scanning Laser Ophthalmoscopy
1
6.9.1.2
Confocal Scanning Laser Polarimetry
1
6.9.2 Optical coherence tomography
0
6.9.2.1
Anterior
6
6.9.2.2
Posterior
92
6.9.5
Other
1
6.10 Fluorescein (ICG) angiography
0
6.10.1 Anterior segment
0
6.10.2 Posterior segment
0
6.11
Bloodflow measurements
36
6.12
Ultrasonography and ultrasound biomicroscopy
8
6.13
Provocative tests
1
6.19
Telemedicine
3
6.20
Progression
26
6.30
Other
38
8 Refractive errors in relation to glaucoma
0
8.1
Myopia
11
8.2 Hypermetropia
0
8.3
Contact lenses
2
8.4
Refractive surgical procedures
1
8.5 Other
0
9 Clinical forms of glaucomas
0
9.1 Developmental glaucomas
0
9.1.1
Congenital glaucoma, Buphthalmos
14
9.1.2
Juvenile glaucoma
23
9.1.3
Syndromes of Axenfeld, Rieger, Peters, aniridia
3
9.1.4 Other
0
9.2 Primary open angle glaucomas
0
9.2.1
Ocular hypertension
1
9.2.2
Other risk factors for glaucoma
12
9.2.3
Open angle glaucoma with elevated IOP
1
9.2.4
Normal pressure glaucoma
21
9.3 Primary angle closure glaucomas
0
9.3.1
Acute primary angle closure glaucoma (pupillary block)
8
9.3.2
Chronic primary angle closure glaucoma (pupillary block)
5
9.3.3
Plateau iris syndrome
2
9.3.4
Primary angle closure suspect
1
9.3.5
Primary angle closure
3
9.3.10
Other
1
9.4 Glaucomas associated with other ocular and systemic disorders
0
9.4.1
Steroid-induced glaucoma
8
9.4.2
Glaucomas associated with disorders of the cornea, conjunctiva, sclera
1
9.4.2.1
Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)
1
9.4.2.2 Posterior polymorphous dystrophy
0
9.4.2.3
Fuchs' endothelial dystrophy
1
9.4.2.5
Other
1
9.4.3 Glaucomas associated with disorders of the iris and ciliary body
0
9.4.3.1
Pigmentary glaucoma
2
9.4.3.5
Other
1
9.4.4 Glaucomas associated with disorders of the lens
0
9.4.4.1
Exfoliation syndrome
27
9.4.4.2
Glaucomas associated with cataracts
3
9.4.4.3 Glaucomas associated with lens dislocation
0
9.4.4.5
Other
1
9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous
0
9.4.5.1
Neovascular glaucoma
7
9.4.5.5
Other
11
9.4.6
Glaucomas associated with inflammation, uveitis
12
9.4.7
Glaucomas associated with ocular trauma
2
9.4.8
Glaucomas associated with intraocular tumors
2
9.4.9
Glaucomas associated with elevated episcleral venous pressure
2
9.4.10
Glaucomas associated with hemorrhage
12
9.4.11
Glaucomas following intraocular surgery
1
9.4.11.1
Ciliary block (malignant) glaucoma
1
9.4.11.2
Glaucomas in aphakia and pseudophakia
11
9.4.11.3 Epithelial, fibrous, and endothelial proliferation
0
9.4.11.4
Glaucomas associated with corneal surgery
8
9.4.11.5
Glaucomas associated with vitreoretinal surgery
2
9.4.15
Glaucoma in relation to systemic disease
57
9.4.20
Other
1
10
Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy
7
11 Medical treatment
0
11.1
General management, indication
10
11.2
Cholinergic drugs
1
11.3 Adrenergic drugs
0
11.3.1 Epinephrine
0
11.3.2 Thymoxamine, dapiprazole
0
11.3.3 Apraclonidine, brimonidine
0
11.3.4
Betablocker
1
11.3.5 Other
0
11.4
Prostaglandins
13
11.5
Carbonic anhydrase inhibitors
1
11.5.1
Systemic
1
11.5.2
Topical
2
11.6 Osmotic treatment
0
11.7 Treatment of bloodflow
0
11.8
Neuroprotection
38
11.9
Gene therapy
1
11.13
Combination therapy
2
11.13.1
Betablocker and pilocarpine
1
11.13.2 Betablocker and carbon anhydrase inhibitor
0
11.13.3
Betablocker and brimonidine
1
11.13.4 Betablocker and prostaglandin
0
11.13.5 Other
0
11.14
Investigational drugs; pharmacological experiments
9
11.15
Other drugs in relation to glaucoma
33
11.16
Vehicles, delivery systems, pharmacokinetics, formulation
22
11.17
Cooperation with medical therapy e.g. persistency, compliance, adherence
11
11.20
Other
3
12 Surgical treatment
0
12.1
General management, indication
9
12.2 Laser iridotomy
0
12.3
Laser iridoplasty
2
12.4
Laser trabeculoplasty and other laser treatment of the angle
10
12.7 Surgical iridectomy
0
12.8 Filtering surgery
0
12.8.1
Without tube implant
23
12.8.2
With tube implant or other drainage devices
84
12.8.3
Non-perforating
10
12.8.4 Using laser
0
12.8.5
Other
10
12.8.10
Woundhealing antifibrosis
12
12.8.11
Complications, endophthalmitis
26
12.9
Trabeculotomy, goniotomy
27
12.10
Cyclodestruction
11
12.11
Cyclodialysis
1
12.12
Cataract extraction
1
12.12.1 Intracapsular
0
12.12.2 Extracapsular
0
12.12.3
Phacoemulsification
8
12.14 Combined cataract extraction and glaucoma surgery
0
12.14.1 Intracapsular
0
12.14.2
Extracapsular
1
12.14.3
Phacoemulsification
31
12.15 Capsulotomy
0
12.16
Vitrectomy
4
12.17
Anesthesia
2
12.20
Other
3
13 Therapeutic prognosis and outcome
0
13.1
Prognostic factors
10
13.2 Outcome
0
13.2.1
IOP
1
13.2.2
Visual field
1
13.2.2.1
Progression
1
13.2.2.2 Improvement
0
13.2.3 Other
0
14
Costing studies; pharmacoeconomics
4
15
Miscellaneous
36
Issue
21-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement